{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:48:14Z","timestamp":1778035694597,"version":"3.51.4"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.2169\/internalmedicine.8020-21","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T22:09:23Z","timestamp":1631916563000},"page":"959-967","source":"Crossref","is-referenced-by-count":3,"title":["The Albumin-bilirubin Score Detects Changes in the Liver Function during Treatment for Budd-Chiari Syndrome: A Retrospective Observational Study"],"prefix":"10.2169","volume":"61","author":[{"given":"Ken","family":"Kageyama","sequence":"first","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Jogo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuji","family":"Sohgawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hagihara","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Uchida-Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lee BB, Villavicencio L, Kim YW, et al. Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. J Vasc Surg 43: 101-108, 2006.","DOI":"10.1016\/j.jvs.2005.09.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Copelan A, Remer EM, Sands M, Nghiem H, Kapoor B. Diagnosis and management of Budd Chiari syndrome: an update. Cardiovasc Intervent Radiol 38: 1-12, 2015.","DOI":"10.1007\/s00270-014-0919-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tripathi D, Macnicholas R, Kothari C, et al. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther 39: 864-872, 2014.","DOI":"10.1111\/apt.12668"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ding PX, Zhang SJ, Li Z, Fu MT, Hua ZH, Zhang WG. Long-term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd-Chiari syndrome. J Gastroenterol Hepatol 31: 222-228, 2016.","DOI":"10.1111\/jgh.13025"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Menon KN, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 350: 578-585, 2004.","DOI":"10.1056\/NEJMra020282"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev Gastroenterol Hepatol 9: 865-875, 2015.","DOI":"10.1586\/17474124.2015.1024224"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. R\u00f6ssle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 135: 394-403, 2004.","DOI":"10.1016\/j.surg.2003.09.005"},{"key":"8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.20064","volume":"39","author":"SD Murad","year":"2004","unstructured":"8. Murad SD, Valla DC, De Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 39: 500-508, 2004.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 44: 1308-1316, 2006.","DOI":"10.1002\/hep.21354"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Perell\u00f3 A, Garc\u00eda-Pag\u00e1n JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 35: 132-139, 2002.","DOI":"10.1053\/jhep.2002.30274"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and\/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 55: 878-884, 2006.","DOI":"10.1136\/gut.2005.071423"},{"key":"12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","volume":"49","author":"LD DeLeve","year":"2009","unstructured":"12. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 49: 1729-1764, 2009.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Martens P, Nevens F. Budd-Chiari syndrome. United European Gastroenterol J 3: 489-500, 2015.","DOI":"10.1177\/2050640615582293"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mukund A, Mittal K, Mondal A, Sarin SK. Anatomic recanalization of hepatic vein and inferior vena cava versus direct intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: overall outcome and midterm transplant-free survival. J Vasc Interv Radiol 29: 790-799, 2018.","DOI":"10.1016\/j.jvir.2018.01.781"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tang TJ, Batts KP, De Groen PC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 35: 338-343, 2001.","DOI":"10.1016\/S0168-8278(01)00131-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of the liver function in patients with hepatocellular carcinoma: a new evidence-based approach - the ALBI grade. J Clin Oncol 33: 550-558, 2015.","DOI":"10.1200\/JCO.2014.57.9151"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kageyama K, Yamamoto A, Jogo A, et al. Usefulness of venous pressure measurement in endovascular treatment of Budd-Chiari syndrome: a retrospective cohort study. Intern Med 58: 2923-2929, 2019.","DOI":"10.2169\/internalmedicine.2704-19"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ren W, Qi X, Yang Z, Han G, Fan D. Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol 25: 830-841, 2013.","DOI":"10.1097\/MEG.0b013e32835eb8d4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ho CH, Chiang CL, Lee FA, et al. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and Child-Pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT). Oncotarget 9: 28818-28829, 2018.","DOI":"10.18632\/oncotarget.25522"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine (Baltimore) 96: e7142, 2017.","DOI":"10.1097\/MD.0000000000007142"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fragaki M, Sifaki-Pistolla D, Orfanoudaki E, Kouroumalis E. Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative? Ann Gastroenterol 32: 626-632, 2019.","DOI":"10.20524\/aog.2019.0417"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hsieh YC, Lee KC, Wang YW, et al. Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: role of ALBI score. PLoS One 13: e0208903, 2018.","DOI":"10.1371\/journal.pone.0208903"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tripathi D, Sunderraj L, Vemala V, et al. Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome. Liver Int 37: 111-120, 2017.","DOI":"10.1111\/liv.13180"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_8020-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:41:50Z","timestamp":1648870910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_8020-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8020-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"article-number":"8020-21"}}